Rates of Recurrent Intestinal Metaplasia and Dysplasia After Successful Endoscopic Therapy of Barrett's Neoplasia by Endoscopic Mucosal Resection vs Endoscopic Submucosal Dissection and Ablation: A Large North American Multicenter Cohort.
Kornpong VantanasiriAbel JosephKaran SachdevaRohit GoyalNikita GargDayyan AdoorAmrit K KambojDon Chamil CodipillyCadman L LeggettKenneth K WangWilliam HarmsenUmar HayatAmitabh ChakAmit BhattPrasad G IyerPublished in: The American journal of gastroenterology (2024)
Patients with BE dysplasia/neoplasia achieving CRIM, initially treated with EMR/ablation, had comparable recurrence rates to ESD/ablation. Randomized trials are needed to confirm these outcomes between the 2 ER techniques.